New reimbursement rules make France an even tougher market
This article was originally published in Clinica
Executive Summary
The long awaited decree on changes to reimbursement procedures for medical devices used in the French private sector has been published and introduces a cut-throat competitive element to obtaining reimbursement that has not existed before. The new decree places a substantial burden on manufacturers to prove that their medical devices consistently offer advantages over other available products and techniques and are competitively priced.